Ticker: $ALGN 🦷 😁 
Price: $136.52 (+5.82%)
Date: August 1, 2025

📉 Straightening Out the Numbers — With Insider Help!

Align Technology—the company behind those discreet little Invisalign aligners—has been caught smiling… and not just because of its dental products. 🪥

🔎 Trigger? Insider Buys. Big Ones.

That’s not just a vote of confidence—it’s a full-on grin. 😬

🏦 Wall Street’s Already Brushed Up

• 96.34% of shares are held by institutions 😱

• 103.24% of the float is institution-owned (yes, that’s not a typo)

• Major holders? Just your friendly neighborhood Vanguard, BlackRock, State Street, Citadel, and T. Rowe.

Basically, Wall Street likes Align more than it likes teeth. 🪙🦷

🔍 For Align Tech ($ALGN)'s Institutional Ownership breakdown, see here. 

🧾 Financials: Still Chewing, But Not Biting Off More Than They Can Chew

Q2’25 Highlights:

• 💵 Revenue: $1.01B (up 3.4% QoQ, down 1.6% YoY)

• 📈 Clear Aligner Revenue: $804.6M (down 3.3% YoY)

• 🦾 Imaging/CAD Services: Up 5.6% YoY

• 💡 Operating Margin: 16.1% GAAP / 21.3% non-GAAP

• 💰 Net income per share: $1.72 (GAAP), $2.49 (non-GAAP)

CEO Joe Hogan’s Wisdom Tooth:

“We're seeing strong consumer interest, but fewer patients converting to clear aligners. Blame tariffs, financing hesitancy, and maybe… the return of the metal mouth 🧲.”

In short: The market’s misaligned. But Joe’s putting his money where his mouth is. 🤑

👉 Want the full picture? Dive into Align Tech ($ALGN)'s financials here.

📉 Why the Stock Got Crooked

• Global headwinds: Tariffs, hesitant buyers, and fewer elective procedures.

• Some ortho clinics shifted back to old-school metal braces 🏗️.

• Clear aligners still cool, but consumers are choosing not to smile back—for now.

🧠 Valuation: Straightening Out the Metrics

Valuation has gone from Hollywood veneers to honest smile. 🦷✨

⚠️ But Wait, Before You Bite...

3 Risks You Can’t Ignore:

1. Competition is fierce — from Danaher, 3M, and nimble upstarts 😤

2. Economic slowdown = fewer braces, more budget priorities 📉

3. Stock market bloat — one 🧸 bear could gum everything up

💡💡💡 Curious about another deep oil exploration play?
Check our takes on UnitedHealth Group or even Oscar Health.

🎯 Final Word: Smile-Worthy or Still Gapped?

Align Technology is in recovery mode. The CEO clearly believes in the company (to the tune of $1M). So do the institutions.

Valuation? ✅ Attractive
Growth potential? ✅ Still there
Risk? ✅ Real
Bottom? 🤷 Maybe not yet — but you're no fool if you're nibbling.

🪥 Pro Tip:

Take care of your teeth as well as your portfolio.
🧼 Floss your stocks. Brush up on your valuations. And don't forget to smile while investing. 

⚠️ Disclaimer:

We’re not financial advisors. We’re FUNancial advisors.
We laugh, we analyze, we meme — we do not provide investment advice. It’s just a second opinion — and yes, we’re billing your sense of humor. 🎪💸 
Invest at your own risk, always DYOR, hold the FOMO, and don’t invest what you can’t afford to lose. 

🧭 Want More Like This?

• 🕵️ Insider Purchases Center
• 📣 Follow the Pundits Hub
• 📈 Young Guns & Turnaround Stocks — Track More Growth (and Growing-Pain) Plays
• 😆 Stock Market Humor & Serious-ish Plays
• 🌍 See the world differently and check out more international market picks and fun takes. Explore International Investment Opportunities and value plays 💸 Cheap Stocks with (Maybe) Big Upside
• 🧟 Corporate Resurrection Series — Our special series on companies rising from the financial grave. 🎯 The “Turnaround or Toast” Series (If it still exists. We’re not sure. Ask the intern.)
• 📈 Biotech Bets & Innovation Radar (Problem is we can't detect the Radar)

😂 Laugh, Learn, Invest: funanc1al.com | Funanc1al: Where Even Finance Meets Funny